Mindset Pharma Inc. CNSX:MSET1 min readMindset Pharma Inc is a drug discovery and development company focused on creating psychedelic medicines to treat neurological and psychiatric disorders.
Nov 16, 2022 Mindset Pharma and PharmAla Enter into Exclusive Sales Agreement for the Sale and Distribution of Pharmaceutical Grade Psilocybin
Nov 14, 2022 Mindset Pharma Presents Poster at Neuroscience 2022 Highlighting Preclinical Data on MSP-1014, its Psilocybin-like Lead Drug Candidate
Oct 05, 2022 Mindset Pharma Selects Lead Clinical Candidates From "Family 2" of its Next Generation Psychedelic Drug Portfolio
Sep 14, 2022 Mindset Pharma Receives Scientific Advice from UK Regulator Facilitating Advancement of Phase 1 First-In-Human Clinical Trial Plan for Its Lead Clinical Candidate, MSP-1014
Sep 07, 2022 Mindset Pharma Files National Patents Protecting Family 1 Application in 16 Different Countries
Aug 31, 2022 Mindset Pharma Further Expands its IP Portfolio with Three Additional Non-Tryptamine Families of Next-Generation Psychedelic Compounds
5m @ 13.1g/t Gold Intersected within 20m Mineralised Zone in First Drill Hole to Test New Target at Titan East
